ANKARA (İGFA) - Ulaştırma ve Altyapı Bakanı Abdulkadir Uraloğlu, Turistik Diyarbakır Ekspresi uğurlama töreninde konuştu. Treni ilk seferine uğurlamaktan büyük memnuniyet duyduğunu belirten Bakan Uraloğlu, vatandaşların Anadolu'nun eşsiz topraklarını arşın arşın geçen ve turizm amaçlı olarak hizmet veren Turistik Doğu...
Haberi OkuİSTANBUL (İGFA) - 31 Mart seçimleri nedeniyle en yoğun seyahat hareketliliği Doğu Anadolu, Güneydoğu Anadolu ve Karadeniz bölgelerinde görülüyor. Türkiye'de 31 Mart Pazar günü gerçekleşecek yerel seçimler, ülke genelindeki seyahatlerde hareketliliği artırıyor. Bu hareketlilik, büyük ölçüde vatandaşların kayıtlı oldukları illere...
Haberi OkuANKARA (İGFA) - Karaman- Konya- Ankara, Karaman - Konya- İstanbul YHT hattının 2 yıllık seyahat verilerine ilişkin değerlendirmelerde bulunan Ulaştırma ve Altyapı Bakanı Abdulkadir Uraloğlu, Türkiye'de 2003 yılıyla birlikte ortaya konulan demiryolu vizyonu sayesinde YHT ile tanışan sekizinci ilin Karaman...
Haberi Oku[padding top="0" bottom="0" right="5%" left="5%"] The mission of the Advanced Liver Diseases Study Group is to become the premier epidemiology, clinical, translational research, and treatment center for advanced liver diseases, cirrhosis, and portal hypertension in the world. Additionally, the mission...
Haberi Oku[padding top="0" bottom="0" right="5%" left="5%"] The mission of the Advanced Liver Diseases Study Group is to become the premier epidemiology, clinical, translational research, and treatment center for advanced liver diseases, cirrhosis, and portal hypertension in the world. Additionally, the mission...
Haberi Oku[padding top="0" bottom="0" right="5%" left="5%"] The mission of the Advanced Liver Diseases Study Group is to become the premier epidemiology, clinical, translational research, and treatment center for advanced liver diseases, cirrhosis, and portal hypertension in the world. Additionally, the mission...
Haberi Oku[padding top="0" bottom="0" right="5%" left="5%"] The mission of the Advanced Liver Diseases Study Group is to become the premier epidemiology, clinical, translational research, and treatment center for advanced liver diseases, cirrhosis, and portal hypertension in the world. Additionally, the mission...
Haberi Oku[padding top="0" bottom="0" right="5%" left="5%"] The mission of the Advanced Liver Diseases Study Group is to become the premier epidemiology, clinical, translational research, and treatment center for advanced liver diseases, cirrhosis, and portal hypertension in the world. Additionally, the mission...
Haberi Oku[padding top="0" bottom="0" right="5%" left="5%"] The mission of the Advanced Liver Diseases Study Group is to become the premier epidemiology, clinical, translational research, and treatment center for advanced liver diseases, cirrhosis, and portal hypertension in the world. Additionally, the mission...
Haberi Oku[padding top="0" bottom="0" right="5%" left="5%"] The mission of the Advanced Liver Diseases Study Group is to become the premier epidemiology, clinical, translational research, and treatment center for advanced liver diseases, cirrhosis, and portal hypertension in the world. Additionally, the mission...
Haberi Oku
